JP2005528413A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528413A5 JP2005528413A5 JP2004500861A JP2004500861A JP2005528413A5 JP 2005528413 A5 JP2005528413 A5 JP 2005528413A5 JP 2004500861 A JP2004500861 A JP 2004500861A JP 2004500861 A JP2004500861 A JP 2004500861A JP 2005528413 A5 JP2005528413 A5 JP 2005528413A5
- Authority
- JP
- Japan
- Prior art keywords
- acrylate
- transdermal
- naphthol
- tetrahydro
- thienyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10220230A DE10220230A1 (de) | 2002-05-06 | 2002-05-06 | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
| DE10220230.3 | 2002-05-06 | ||
| PCT/EP2003/004685 WO2003092677A1 (de) | 2002-05-06 | 2003-05-05 | Transepikutane darreichungsform zur behandlung des restless leg syndroms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010098924A Division JP2010159302A (ja) | 2002-05-06 | 2010-04-22 | レストレスレッグス症候群を処置するための経外角皮的投与形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005528413A JP2005528413A (ja) | 2005-09-22 |
| JP2005528413A5 true JP2005528413A5 (https=) | 2006-02-16 |
| JP5253707B2 JP5253707B2 (ja) | 2013-07-31 |
Family
ID=29285132
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004500861A Expired - Lifetime JP5253707B2 (ja) | 2002-05-06 | 2003-05-05 | レストレスレッグス症候群を処置するための経外角皮的投与形 |
| JP2010098924A Pending JP2010159302A (ja) | 2002-05-06 | 2010-04-22 | レストレスレッグス症候群を処置するための経外角皮的投与形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010098924A Pending JP2010159302A (ja) | 2002-05-06 | 2010-04-22 | レストレスレッグス症候群を処置するための経外角皮的投与形 |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1501499B1 (https=) |
| JP (2) | JP5253707B2 (https=) |
| KR (1) | KR20040104697A (https=) |
| CN (1) | CN100396281C (https=) |
| AT (1) | ATE387912T1 (https=) |
| AU (1) | AU2003233233B2 (https=) |
| BR (1) | BR0309837A (https=) |
| CA (2) | CA2483120C (https=) |
| CY (1) | CY1107452T1 (https=) |
| DE (2) | DE10220230A1 (https=) |
| DK (1) | DK1501499T3 (https=) |
| ES (1) | ES2301795T3 (https=) |
| IL (2) | IL164861A0 (https=) |
| MX (1) | MXPA04010687A (https=) |
| NO (1) | NO333619B1 (https=) |
| NZ (1) | NZ536533A (https=) |
| PL (1) | PL218549B1 (https=) |
| PT (1) | PT1501499E (https=) |
| RU (1) | RU2301063C9 (https=) |
| SI (1) | SI1501499T1 (https=) |
| UA (1) | UA81625C2 (https=) |
| WO (1) | WO2003092677A1 (https=) |
| ZA (1) | ZA200408862B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| DE10359528A1 (de) | 2003-12-18 | 2005-07-28 | Schwarz Pharma Ag | (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum |
| MY149152A (en) | 2006-05-08 | 2013-07-15 | Teikoku Seiyaku Kk | Percutaneous absorption preparations of antimentia drugs |
| TWI392670B (zh) | 2006-06-22 | 2013-04-11 | Ucb Pharma Gmbh | 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途 |
| EP1987815A1 (en) * | 2007-05-04 | 2008-11-05 | Schwarz Pharma Ag | Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
| NZ584363A (en) | 2007-11-28 | 2012-11-30 | Ucb Pharma Gmbh | Drug formulations of Rotigotine which comprise the thermodynamically stable polymorphic form 2 |
| US9155725B2 (en) | 2008-02-27 | 2015-10-13 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive skin patch and packaged product |
| EP2255809B1 (en) * | 2008-02-27 | 2017-08-23 | Hisamitsu Pharmaceutical Co., Inc. | Medicated patch |
| EP2201941A1 (de) | 2008-12-29 | 2010-06-30 | UCB Pharma GmbH | Pflaster-Herstellungstechnologie |
| EP2281559A1 (en) | 2009-06-26 | 2011-02-09 | UCB Pharma GmbH | Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis |
| LT3257504T (lt) | 2009-12-22 | 2024-08-26 | UCB Biopharma SRL | Polivinilpirolidonas, skirtas nekristalinės formos kietos rotigotino dispersijos stabilizavimui |
| US8729306B2 (en) | 2010-02-05 | 2014-05-20 | Ucb Pharma Gmbh | Process for the preparation of nitrogen substituted aminotetralins derivatives |
| BR112012029944A2 (pt) | 2010-06-25 | 2019-09-24 | Ucb Pharma Gmbh | processo para preparação de derivados de aminotetralinas substituídas com nitrogênio |
| EP2559435A1 (en) | 2011-08-19 | 2013-02-20 | UCB Pharma GmbH | Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke |
| WO2013075823A1 (en) | 2011-11-22 | 2013-05-30 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermal therapeutic system comprising rotigotine and crystallization inhibitor |
| DE102012013439A1 (de) | 2012-07-03 | 2014-01-23 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System umfassend Rotigotin und Kristallisationsinhibitor |
| DE102012013421A1 (de) | 2012-07-03 | 2014-01-09 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System (TTS) mit Rotigotin |
| MX2015000049A (es) * | 2012-07-05 | 2015-04-08 | Sk Chemicals Co Ltd | Preparacion absorbible transdermicamente que contiene rotigotina. |
| EP2870963A4 (en) * | 2012-07-06 | 2016-03-09 | Sk Chemicals Co Ltd | PREPARATION CONTAINING ROTIGOTINE FOR PERCUTANEOUS ABSORBING |
| TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片 |
| JP6726096B2 (ja) | 2013-07-03 | 2020-07-22 | エルテーエス ローマン テラピー−システメ アーゲー | 電子部品を有する経皮治療システム |
| WO2015129527A1 (ja) | 2014-02-27 | 2015-09-03 | 株式会社メドレックス | プラミペキソールを含有する神経変性疾患の治療用貼付剤 |
| CA2948219C (en) | 2014-05-20 | 2023-04-04 | Lts Lohmann Therapie-Systeme Ag | Method for adjusting the release of active agent in a transdermal delivery system |
| CN106456566B (zh) | 2014-05-20 | 2020-06-16 | Lts勒曼治疗系统股份公司 | 含罗替戈汀的经皮递送系统 |
| US11752110B2 (en) | 2014-05-20 | 2023-09-12 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
| JP6872675B1 (ja) | 2019-06-14 | 2021-05-19 | 久光製薬株式会社 | ロチゴチン含有貼付剤 |
| ES2966170T3 (es) | 2020-01-24 | 2024-04-18 | Luye Pharma Switzerland Ag | Sistema terapéutico transdérmico que comprende rotigotina y al menos un adhesivo de silicona no resistente a las aminas |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5232702A (en) * | 1991-07-22 | 1993-08-03 | Dow Corning Corporation | Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices |
| DE4238223C1 (de) * | 1992-11-12 | 1994-05-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
| US5482988A (en) * | 1994-01-14 | 1996-01-09 | Dow Corning Corporation | Hot-melt silicone pressure sensitive adhesive with siloxylated polyether waxes as additives |
| IL116539A (en) * | 1995-01-06 | 2002-02-10 | Noven Pharma | Preparations given through the skin of unstable anti-acid drugs |
| FR2749514B1 (fr) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel | Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament |
| DE19701619B4 (de) * | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
| DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
| DE19938823A1 (de) * | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
| DE19938825A1 (de) * | 1999-08-19 | 2001-04-26 | Boehringer Ingelheim Pharma | Wirkstoffkombination mit Clonidin |
| DE10041479A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 |
| ATE246919T1 (de) * | 2001-05-08 | 2003-08-15 | Sanol Arznei Schwarz Gmbh | Verbessertes transdermales therapeutisches system zur behandlung von morbus parkinson |
| EP1256339B1 (en) * | 2001-05-08 | 2003-10-15 | Schwarz Pharma Ag | Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine |
-
2002
- 2002-05-06 DE DE10220230A patent/DE10220230A1/de not_active Ceased
-
2003
- 2003-05-05 MX MXPA04010687A patent/MXPA04010687A/es active IP Right Grant
- 2003-05-05 UA UA20041109078A patent/UA81625C2/ru unknown
- 2003-05-05 JP JP2004500861A patent/JP5253707B2/ja not_active Expired - Lifetime
- 2003-05-05 KR KR10-2004-7017685A patent/KR20040104697A/ko not_active Ceased
- 2003-05-05 PL PL373276A patent/PL218549B1/pl unknown
- 2003-05-05 ES ES03727432T patent/ES2301795T3/es not_active Expired - Lifetime
- 2003-05-05 SI SI200331195T patent/SI1501499T1/sl unknown
- 2003-05-05 DK DK03727432T patent/DK1501499T3/da active
- 2003-05-05 AT AT03727432T patent/ATE387912T1/de active
- 2003-05-05 PT PT03727432T patent/PT1501499E/pt unknown
- 2003-05-05 CN CNB038160250A patent/CN100396281C/zh not_active Expired - Fee Related
- 2003-05-05 AU AU2003233233A patent/AU2003233233B2/en not_active Ceased
- 2003-05-05 IL IL16486103A patent/IL164861A0/xx unknown
- 2003-05-05 EP EP03727432A patent/EP1501499B1/de not_active Revoked
- 2003-05-05 WO PCT/EP2003/004685 patent/WO2003092677A1/de not_active Ceased
- 2003-05-05 RU RU2004131866/15A patent/RU2301063C9/ru active
- 2003-05-05 CA CA2483120A patent/CA2483120C/en not_active Expired - Fee Related
- 2003-05-05 DE DE50309318T patent/DE50309318D1/de not_active Expired - Lifetime
- 2003-05-05 CA CA2787384A patent/CA2787384A1/en not_active Abandoned
- 2003-05-05 NZ NZ536533A patent/NZ536533A/en not_active IP Right Cessation
- 2003-05-05 BR BR0309837-0A patent/BR0309837A/pt not_active Application Discontinuation
-
2004
- 2004-10-27 IL IL164861A patent/IL164861A/en active IP Right Grant
- 2004-11-02 ZA ZA2004/08862A patent/ZA200408862B/en unknown
- 2004-11-30 NO NO20045240A patent/NO333619B1/no not_active IP Right Cessation
-
2008
- 2008-05-02 CY CY20081100471T patent/CY1107452T1/el unknown
-
2010
- 2010-04-22 JP JP2010098924A patent/JP2010159302A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005528413A5 (https=) | ||
| JP5253707B2 (ja) | レストレスレッグス症候群を処置するための経外角皮的投与形 | |
| US9265752B2 (en) | Transdermal patch containing Rotigotine | |
| JP5542665B2 (ja) | マトリックス型経皮投与剤およびその製造方法 | |
| KR20220082098A (ko) | 도네페질 경피 전달 시스템 | |
| RU2764764C2 (ru) | Трансдермальные системы доставки мемантина | |
| JP2013056944A (ja) | メチルフェニデートで注意欠乏障害及び注意欠乏／活動亢進障害を治療する組成物及び方法 | |
| JP2006528144A (ja) | プラミペキソール活性剤を含む経皮治療システム | |
| JP2017519837A (ja) | 経皮送達システム | |
| JP3159688B2 (ja) | 経皮吸収テープ剤 | |
| WO2000019986A1 (en) | Tape material for transcutaneous absorption | |
| CN104797245B (zh) | 丙炔基氨基茚满透皮组合物 | |
| US20170071880A1 (en) | Selegiline transdermal system | |
| JP7716111B2 (ja) | 神経変性疾患の症状の緩和又は治療のための貼付剤 | |
| CN102970974B (zh) | 用于治疗皮炎和牛皮癣的去炎松缩酮制剂 | |
| CN117919208A (zh) | 秋水仙碱的透皮贴剂及其用途 | |
| HK1072541B (en) | Trans-epicutaneous administration form for treating restless leg syndrome | |
| HK1142805A (en) | Composition comprising rotigotine, its use and transdermal patch comprising the composition | |
| HK1207558B (zh) | 丙炔基氨基茚满透皮组合物 | |
| HK1031196B (en) | Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |